AU2012262534B2 - Method of determining vasoreactivity using inhaled nitric oxide - Google Patents
Method of determining vasoreactivity using inhaled nitric oxide Download PDFInfo
- Publication number
- AU2012262534B2 AU2012262534B2 AU2012262534A AU2012262534A AU2012262534B2 AU 2012262534 B2 AU2012262534 B2 AU 2012262534B2 AU 2012262534 A AU2012262534 A AU 2012262534A AU 2012262534 A AU2012262534 A AU 2012262534A AU 2012262534 B2 AU2012262534 B2 AU 2012262534B2
- Authority
- AU
- Australia
- Prior art keywords
- patient
- vasoactive agent
- hemodynamics
- indicator
- pulmonary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pathology (AREA)
- Anesthesiology (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161490929P | 2011-05-27 | 2011-05-27 | |
| US61/490,929 | 2011-05-27 | ||
| PCT/US2012/039401 WO2012166534A1 (en) | 2011-05-27 | 2012-05-24 | Method of determining vasoreactivity using inhaled nitric oxide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2012262534A1 AU2012262534A1 (en) | 2013-12-12 |
| AU2012262534B2 true AU2012262534B2 (en) | 2016-06-02 |
Family
ID=47259769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012262534A Ceased AU2012262534B2 (en) | 2011-05-27 | 2012-05-24 | Method of determining vasoreactivity using inhaled nitric oxide |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11154210B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2713723B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2014527025A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012262534B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2837341C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012166534A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7618594B2 (en) | 2004-08-18 | 2009-11-17 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| WO2006023616A2 (en) * | 2004-08-18 | 2006-03-02 | Geno Llc | Conversion of nitrogen dioxide (no2) to nitric oxide (no) |
| AU2009209181B2 (en) | 2008-01-28 | 2014-01-16 | VERO Biotech LLC. | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| US8607785B2 (en) | 2008-08-21 | 2013-12-17 | Geno Llc | Systems and devices for generating nitric oxide |
| US8613958B2 (en) | 2009-06-22 | 2013-12-24 | Geno Llc | Nitric oxide therapies |
| AU2012262534B2 (en) | 2011-05-27 | 2016-06-02 | VERO Biotech LLC. | Method of determining vasoreactivity using inhaled nitric oxide |
| WO2015160777A1 (en) | 2014-04-15 | 2015-10-22 | Commscope Technologies Llc | Wideband remote unit for distributed antenna system |
| PT3970730T (pt) * | 2016-02-12 | 2024-07-30 | Mallinckrodt Pharmaceuticals Ireland Ltd | Sistema para utilização e monitorização de óxido nítrico inalado com dispositivos de ajuda ventricular esquerda |
| JP6704094B2 (ja) | 2017-02-27 | 2020-06-03 | サード ポール, インコーポレイテッドThird Pole, Inc. | 酸化窒素を生成するためのシステムおよび方法 |
| MX2019009931A (es) | 2017-02-27 | 2020-07-14 | Third Pole Inc | Sistemas y metodos para generacion ambulatoria de oxido nitrico. |
| MX2020010523A (es) | 2017-02-27 | 2021-02-09 | Third Pole Inc | Sistemas y metodos para generar oxido nitrico. |
| US11672938B1 (en) | 2018-07-18 | 2023-06-13 | Vero Biotech LLC | Start-up protocols for nitric oxide delivery device |
| WO2020074957A1 (en) * | 2018-10-12 | 2020-04-16 | Sanotize Research And Development Corp. | Gas-evolving compositions and container and delivery systems |
| WO2020232414A1 (en) | 2019-05-15 | 2020-11-19 | Third Pole, Inc. | Architectures for production of nitric oxide |
| WO2020232419A1 (en) | 2019-05-15 | 2020-11-19 | Third Pole, Inc. | Systems and methods for generating nitric oxide |
| EP3969415A4 (en) | 2019-05-15 | 2023-08-16 | Third Pole, Inc. | ELECTRODES FOR GENERATING NITROUS OXIDE |
| EP4069069A4 (en) | 2020-01-11 | 2024-07-03 | Third Pole, Inc. | SYSTEMS AND METHODS FOR NITROGEN OXIDE PRODUCTION WITH HUMIDITY CONTROL |
| EP4167920A4 (en) | 2020-06-18 | 2024-06-12 | Third Pole, Inc. | Systems and methods for preventing and treating infections with nitric oxide |
| WO2022082072A1 (en) | 2020-10-16 | 2022-04-21 | Third Pole, Inc. | Nitric oxide generation process controls |
| WO2023049873A1 (en) | 2021-09-23 | 2023-03-30 | Third Pole, Inc. | Systems and methods for delivering nitric oxide |
| US12569628B2 (en) | 2022-04-14 | 2026-03-10 | Third Pole, Inc. | Delivery of medicinal gas in a liquid medium |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006063215A2 (en) * | 2004-12-08 | 2006-06-15 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of pulmonary hypertension of the newborn |
| WO2011002606A1 (en) * | 2009-06-30 | 2011-01-06 | Ikaria Holdings, Inc. | Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation |
| WO2012075420A1 (en) * | 2010-12-03 | 2012-06-07 | Geno Llc | Nitric oxide treatments |
| WO2012151701A1 (en) * | 2011-05-10 | 2012-11-15 | Université Laval / Vice-Rectorat À La Recherche Et À La Création | Methods for the treatment and diagnostic of pulmonary arterial hypertension |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6758214B2 (en) | 2000-01-28 | 2004-07-06 | Cyterra Corporation | Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment |
| US7040313B2 (en) | 2001-09-05 | 2006-05-09 | Cyterra Corporation | Method and apparatus for nitric oxide generation |
| US7618594B2 (en) | 2004-08-18 | 2009-11-17 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| WO2006023616A2 (en) | 2004-08-18 | 2006-03-02 | Geno Llc | Conversion of nitrogen dioxide (no2) to nitric oxide (no) |
| WO2007087575A2 (en) * | 2006-01-24 | 2007-08-02 | University Of Chicago | Compositions and methods for treating pulmonary hypertension |
| AU2008232413B2 (en) | 2007-03-23 | 2013-09-19 | VERO Biotech LLC. | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| AU2009209181B2 (en) | 2008-01-28 | 2014-01-16 | VERO Biotech LLC. | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| WO2010011928A1 (en) | 2008-07-24 | 2010-01-28 | Geno Llc | Methods for diagnosing and treating a heart condition in a patient |
| US10780241B2 (en) | 2008-08-21 | 2020-09-22 | Vero Biotech LLC | Devices and methods for minimizing and treating high-altitude sickness |
| US10960168B2 (en) | 2008-08-21 | 2021-03-30 | Vero Biotech LLC | Delivery of high concentration nitric oxide |
| US8701657B2 (en) | 2008-08-21 | 2014-04-22 | Geno Llc | Systems for generating nitric oxide |
| US8607785B2 (en) | 2008-08-21 | 2013-12-17 | Geno Llc | Systems and devices for generating nitric oxide |
| EP2362810A4 (en) | 2008-09-22 | 2013-09-11 | Geno Llc | CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITROGEN MONOXIDE (NO) |
| US8613958B2 (en) | 2009-06-22 | 2013-12-24 | Geno Llc | Nitric oxide therapies |
| JP5995724B2 (ja) * | 2009-11-20 | 2016-09-21 | ゲノ エルエルシー | 一酸化窒素送達システム |
| US20120093948A1 (en) * | 2009-11-20 | 2012-04-19 | Fine David H | Nitric Oxide Treatments |
| WO2011137122A1 (en) | 2010-04-26 | 2011-11-03 | Geno Llc | Nitrosyl special connector |
| CA2797702C (en) | 2010-04-26 | 2020-03-10 | VERO Biotech LLC. | Delivery of ultra pure nitric oxide (no) |
| USD688352S1 (en) | 2010-04-27 | 2013-08-20 | Geno Llc | Female gas connector |
| USD679366S1 (en) | 2010-04-27 | 2013-04-02 | Geno Llc | Male gas connector |
| AU2012262534B2 (en) | 2011-05-27 | 2016-06-02 | VERO Biotech LLC. | Method of determining vasoreactivity using inhaled nitric oxide |
| EP4180078A1 (en) | 2014-10-20 | 2023-05-17 | VERO Biotech LLC | Nitrogen dioxide storage cassette |
-
2012
- 2012-05-24 AU AU2012262534A patent/AU2012262534B2/en not_active Ceased
- 2012-05-24 CA CA2837341A patent/CA2837341C/en active Active
- 2012-05-24 JP JP2014512110A patent/JP2014527025A/ja active Pending
- 2012-05-24 EP EP12793863.7A patent/EP2713723B1/en active Active
- 2012-05-24 WO PCT/US2012/039401 patent/WO2012166534A1/en not_active Ceased
-
2013
- 2013-01-07 US US13/735,558 patent/US11154210B2/en active Active
-
2017
- 2017-03-27 JP JP2017061811A patent/JP2017165731A/ja not_active Ceased
-
2019
- 2019-02-28 JP JP2019035311A patent/JP2019131556A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006063215A2 (en) * | 2004-12-08 | 2006-06-15 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of pulmonary hypertension of the newborn |
| WO2011002606A1 (en) * | 2009-06-30 | 2011-01-06 | Ikaria Holdings, Inc. | Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation |
| WO2012075420A1 (en) * | 2010-12-03 | 2012-06-07 | Geno Llc | Nitric oxide treatments |
| WO2012151701A1 (en) * | 2011-05-10 | 2012-11-15 | Université Laval / Vice-Rectorat À La Recherche Et À La Création | Methods for the treatment and diagnostic of pulmonary arterial hypertension |
Non-Patent Citations (1)
| Title |
|---|
| Oudiz, R. et al., Advances in Pulmonary Hypertension: Official Journal of the Pulmonary Hypertension Association, 2005, vol. 4, no. 3, pages 15-25. * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019131556A (ja) | 2019-08-08 |
| EP2713723B1 (en) | 2018-09-12 |
| WO2012166534A1 (en) | 2012-12-06 |
| JP2017165731A (ja) | 2017-09-21 |
| CA2837341C (en) | 2021-10-19 |
| US11154210B2 (en) | 2021-10-26 |
| US20130309328A1 (en) | 2013-11-21 |
| AU2012262534A1 (en) | 2013-12-12 |
| EP2713723A1 (en) | 2014-04-09 |
| EP2713723A4 (en) | 2015-03-25 |
| CA2837341A1 (en) | 2012-12-06 |
| JP2014527025A (ja) | 2014-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11154210B2 (en) | Method of determining vasoreactivity using inhaled nitric oxide | |
| Kharitonov et al. | Exhaled markers of pulmonary disease | |
| Pijnenburg et al. | Exhaled nitric oxide in childhood asthma: a review | |
| Du et al. | Combining central venous-to-arterial partial pressure of carbon dioxide difference and central venous oxygen saturation to guide resuscitation in septic shock | |
| JP2015145376A (ja) | 患者における心臓の病気の診断及び治療方法 | |
| Marshall | A comparison of methods of measuring the diffusing capacity of the lungs for carbon monoxide. Investigation by fractional analysis of the alveolar air | |
| JP2005518838A (ja) | 肺機能を測定するための13c標識物質の使用 | |
| Gabrielli et al. | Systemic oxidative stress and endothelial dysfunction is associated with an attenuated acute vascular response to inhaled prostanoid in pulmonary artery hypertension patients | |
| US20180000859A1 (en) | Systems andmethods to improve organor tissue function andorganor tissue transplant longevity | |
| Lahzami et al. | Small airways function declines after allogeneic haematopoietic stem cell transplantation | |
| Grasemann et al. | Metabolites of nitric oxide in the lower respiratory tract of children | |
| Hubert et al. | Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments | |
| Yoon et al. | Pulmonary dysfunction is possibly a marker of malnutrition and inflammation but not mortality in patients with end-stage renal disease | |
| TW200744701A (en) | Test agent for diagnosing dyspepsia | |
| Varela et al. | N-Terminal fragment of pro-brain natriuretic peptide plasma concentration: A new predictive biomarker for community-acquired pneumonia? | |
| Habedank et al. | Vasodilation and exercise capacity in patients with end-stage renal disease: a prospective proof-of-concept study | |
| Baur et al. | Determination of exhaled nitric oxide in respiratory diseases | |
| JP6041377B2 (ja) | 生体内活性酸素量の測定法 | |
| ÖZTUNA et al. | Effect of nasal continuous positive airway pressure on global right ventricular myocardial performance in patients with obstructive sleep apnea syndrome | |
| Morris | Pulmonary diseases | |
| Galvin et al. | Comparison of three methods for measuring cigarette smoking in patients with vascular disease | |
| Eyre et al. | MCQs and SBAs in Intensive Care Medicine | |
| RU2413944C1 (ru) | Способ оценки тяжести острых отравлений опиоидами | |
| Roy | Nitric Oxide in Chronic Obstructive Pulmonary Disease: Measurement and Role in the Characterisation of Disease | |
| Kim et al. | Fractional exhaled nitric oxide: indications and interpretation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| HB | Alteration of name in register |
Owner name: VERO BIOTECH LLC. Free format text: FORMER NAME(S): GENO LLC |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |